RE:RE:RE:RE:FDA approval? Tripp mentioned they had people in the queue for Aristotle already with Care oncology. He also expected COVID testing to increase with delta variant and back to school to the revenue levels of Q1.
So I'm expecting a decent quarter nothing big but the real start of Aristotle testing will be q4 with what we have seen of upcoming web pages and shipping/partnerships via quest diagnostics and phlebfinders
If they can stay cash flow positive or at a couple million spend with $4 million in the bank that will set them up nicely as Aristotle and Care oncology and the new websites and marketing start to take off.
anw
skiboard09 wrote:
I think cancer testing won't be to existing yet. Hopefully next q it will show some progress. Be great for Tripp to prove market wrong for once.
HCW presentation was very good. Lots of companies participating there. Would be nice to get some traction